Results of Open-label Extension of the ORIGIN Study – Explore the Visual Abstract
This visual abstract was supported by Vera Therapeutics. Download Visual Abstract
This visual abstract was supported by Vera Therapeutics. Download Visual Abstract
Anita Layton, from the University of Waterloo, Canada, will present the WCN’25 Stewart Cameron Lecture, “Mathematics as a Microscopy: Modeling Kidney Disease.” This plenary session will explore how mathematical modeling can shed light on kidney disease and its underlying mechanisms. Professor Layton will explore the role of sex and circadian rhythms in kidney function and...
The ISN congratulates its newest ISN-Named Fellows: Megan Borkum and Neeru Agarwal for ISN-ACT (clinical trials) Rajitha A. Abeysekera for SharE-RR (registries) Somkanya Tungsanga, Nivedita Kamath, Victoria Nkunu, Caner Alparslan, Viviane Calice-Silva, Abduzhappar Gaipov, Anna Francis and Maria Pippias, for ISN-GKHA (ISN-Global Kidney Health Atlas) Learn more about our ISN-Named Fellows here These early-career ISN members were approved as ISN-Named...
Are you exploring the potentially transformative role of artificial intelligence (AI) in kidney care? The ISN Academy invites ISN members to submit their innovative AI-related projects for an opportunity to be featured in a new educational series. Find out more and submit your proposal here Selected contributors will deliver a 10–15-minute presentation and participate in a...
Download PDF A groundbreaking study led by ISN members as part of the Kidney Care Network (KCN) initiative has been published in PLOS Medicine. This research provides critical insights into acute kidney disease (AKD) in low- and lower-middle-income countries (LLMICs) and proposes actionable solutions to address gaps in care. Read the publication here Why this study matters AKD...
In September, the ISN launched an online petition urging everyone to join the movement to elevate kidney disease as a critical health priority. The Guatemalan government also has contributed to raising kidney health awareness globally by submitting a kidney health resolution to the World Health Organization. This resolution calls for urgent global action to address...
Two significant research studies were accepted as late-breaking clinical trials at Kidney Week 2024 and have subsequently been published in Kidney International®. Higher Intraoperative Blood Pressure Does Not Reduce Acute Kidney Injury in Non-Cardiac Surgery: What Do the Results of the POISE-3 Trial Tell Us? The POISE-3 trial's analysis found no benefit in targeting a...
ISN Fellow Ahmad Naseer Kaihan, from Afghanistan, completed an intensive 12-month training program from May 2023 to May 2024 under the guidance of Professor Shoichi Maruyama at Nagoya University in Japan. Dr. Kaihan comments: “Professor Maruyama and Professor Yasuda’s mentorship and support have been invaluable to my growth and development. Their guidance has given me...
The ISN has expanded its “Cardio-Kidney-Metabolic (CKM) Initiative” with the launch of a new interactive CKM roadmap designed to help clinicians manage patients with cardio-kidney-metabolic conditions and complications. Access the roadmap here Kidney, cardiovascular, and metabolic diseases are closely linked, contributing significantly to morbidity and mortality worldwide. Launched in 2022, the CKM initiative brings nephrologists and...
The “Primer Course in Glomerular Diseases” offers comprehensive updates on glomerulonephritis diagnosis and management, including histopathology, treatments, and clinicopathological cases, with expert-led discussions on practical applications. Over 330 people have benefitted from previous editions of this course in Japan, Argentina, and China. Explore the program In 2025, three such courses will be held on different continents...
Kidney International® A Randomized, Open-label Clinical Trial Examined the Effects of Canagliflozin on Albuminuria and eGFR Decline Using An Individual Pre-Intervention eGFR Slope The CANPIONE study showed that canagliflozin significantly reduced albuminuria by 30.8% and slowed eGFR decline in patients with type 2 diabetes and microalbuminuria. Using a novel design comparing eGFR slopes before and during treatment,...
The ISN PARADIGM meeting took place in Vancouver, BC, Canada, from November 22-23, 2024. The meeting gathered clinicians, trialists, patient partners, regulators, and industry scientists to rethink current concepts of laboratory values in chronic kidney disease (CKD) populations, the value of patient-reported outcomes, and trial designs while fostering a robust culture of clinical trials. The program...
Brussels, November 26, 2024 The International Society of Nephrology (ISN) is pleased to announce a significant milestone in the global fight against kidney disease. On October 28, 2024, the Government of Guatemala formally requested the World Health Organization (WHO) to adopt a kidney health resolution. The WHO Executive Board member countries will further negotiate this...
The ISN endorses high-quality educational and scientific events worldwide in the kidney care community. Whether your event is big or small, if it addresses region-relevant topics, it could qualify for our endorsement. Apply for ISN endorsement for enhanced visibility, scientific merit, and educational impact. Discover all the benefits of ISN-endorsed meetings and how to apply...
Presentations on trending topics in kidney care will take center stage at WCN'25, offering exciting opportunities for learning and discovery. From precision medicine and artificial intelligence to bioengineering and organ regeneration, WCN'25 will showcase the latest advancements in these emerging areas of kidney care. Here's a preview of what's ahead. Access the searchable scientific program...
The ISN-ACT (Advancing Clinical Trials) team presents this monthly round up of randomized trials in nephrology. Trials are selected not just for impact, but also to showcase the diversity of research produced by the global nephrology community. Each trial is reviewed in context and has a risk of bias assessment. We hope to drive...
The ISN Academy is committed to delivering high-quality educational resources to kidney health professionals worldwide. This fall, we've hosted a range of impactful webinars featuring simultaneous translation that have resonated with our community, including: Unlocking the Future: Artificial Intelligence in Dialysis Natural Disasters and Nephrology: Geographic Impacts, Organizational Responses, and International Insights Advancements and Innovations in IgA...
The ISN recognizes the importance of global research initiatives in advancing its mission for equitable kidney health worldwide. To this end, it has convened several global consortia or networks to address different facets of research, including the rapidly evolving challenge of chronic kidney disease of unknown origin (CKDu). The ISN i3C (CKDu) Network (International Consortium...
The “ISN Global Kidney Trials Insights: A Guide for Everyone” has expanded to include two new case studies. Based on the ISN-ACT Global Trials Focus (GTF) summaries, the guide translates complex trial findings into accessible information to help those living with kidney diseases and others better understand advancements in kidney care. Access the simplified summaries...
The ISN is pleased to announce the signing of a new Memorandum of Understanding with the Asociación Latinoamericana de Nefrología Pediátrica (ALANEPE). Established in 1981, ALANEPE represents pediatric nephrology specialists in the region and is affiliated with the International Pediatric Nephrology Association. By joining forces, the ISN and ALANEPE aim to foster collaboration to address shared...
